What are androgens?

What are androgens?
Androgens are male sex hormones.  The two most common are testosterone and dihydrotestosterone (DHT).  Women have small amounts of androgens too.  Like all hormones, androgens affect the actions of cells and tissues in the body.  Most testosterone is produced in the testicles, but a small amount is made by the adrenal glands (just above the kidneys).  Prostate cancer cells can also produce testosterone.
What do androgens and prostate cancer have to do with each other?
Androgens are needed to ensure that the prostate grows and functions normally.  Androgens can lead to prostate cancer, because they bind to and activate (turn on) the ‘androgen receptor’, a protein that is produced by the cells in the prostate gland.   Once these androgen receptors have been bound to androgen, they then stimulate certain genes that cause prostate cells to grow. 
At early stages of prostate cancer, prostate cancers “feed off” androgens, depending on them to grow.  These types of prostate cancers are known as “androgen-dependent” or “androgen-sensitive”.  Androgen Deprivation Therapy (ADT) works to ‘deprive’ these prostate cells of androgen, thus inhibiting their development.
Unfortunately in men with more advanced cancer, most prostate cancers will eventually continue to grow even when there is a low level of androgens in the body – a phenomenon known as “castration resistant prostate cancer”.

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive